机构：[1]Chinese Acad Med Sci, Med Oncol Canc Hosp, Beijing, Peoples R China[2]Peking Union Med Coll, Beijing, Peoples R China[3]Shanghai Med Univ, Canc Hosp, Shanghai, Peoples R China[4]Capital Med Univ, Bejing Tongren Hosp, Beijing, Peoples R China首都医科大学附属同仁医院
第一作者机构：[1]Chinese Acad Med Sci, Med Oncol Canc Hosp, Beijing, Peoples R China[2]Peking Union Med Coll, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Zhu Y.,Xing P.,Shan L.,et al.A retrospective study in Chinese patients: Is there a role of nanoparticle albumin bound paclitaxel in advanced NSCLC?[J].ANNALS OF ONCOLOGY.2017,28:
APA：
Zhu, Y.,Xing, P.,Shan, L.,Chen, S.,Hao, X.&Li, J..(2017).A retrospective study in Chinese patients: Is there a role of nanoparticle albumin bound paclitaxel in advanced NSCLC?.ANNALS OF ONCOLOGY,28,
MLA：
Zhu, Y.,et al."A retrospective study in Chinese patients: Is there a role of nanoparticle albumin bound paclitaxel in advanced NSCLC?".ANNALS OF ONCOLOGY 28.(2017)
医学